Enzo Biochem (NYSE:ENZ) encountered a drop of 62% or -580,977 shares in the short positions. The number dropped from 937,411 on May 31,2016 to 356,434 on June 15,2016. The final interest is 0.9% of the floated stock. The days to cover figure of 1 can be arrived using the average daily exchange of 301,755 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
Enzo Biochem (NYSE:ENZ): The stock opened at $5.60 on Friday but the bulls could not build on the opening and the stock topped out at $5.93 for the day. The stock traded down to $5.60 during the day, due to lack of any buying support eventually closed down at $5.79 with a loss of -2.20% for the day. The stock had closed at $5.92 on the previous day. The total traded volume was 4,008,005 shares.
The company shares have rallied 96.94% from its 1 Year high price. On Jun 2, 2016, the shares registered one year high at $6.53 and the one year low was seen on Aug 26, 2015. The 50-Day Moving Average price is $5.99 and the 200 Day Moving Average price is recorded at $4.95.
Stocks of Enzo Biochem (NYSE:ENZ) rallied by 6.24% during the past week but lost 6.31% on a 4-week basis. The company has outperformed the S&P 500 by 8% in the past week but underperformed the index by 3.48% in the last 4 weeks.
Enzo Biochem, Inc. (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.